# IDEAYA Biosciences, Inc. (IDYA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from IDEAYA Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/IDYA/mda/fy2025/): filed 2026-02-17; accession 0001193125-26-054533 (https://www.sec.gov/Archives/edgar/data/1676725/000119312526054533/idya-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/IDYA/mda/fy2024/): filed 2025-02-18; accession 0000950170-25-022183 (https://www.sec.gov/Archives/edgar/data/1676725/000095017025022183/idya-20241231.htm)
- [FY 2023 MD&A](/company/IDYA/mda/fy2023/): filed 2024-02-20; accession 0000950170-24-017093 (https://www.sec.gov/Archives/edgar/data/1676725/000095017024017093/idya-20231231.htm)
- [FY 2022 MD&A](/company/IDYA/mda/fy2022/): filed 2023-03-07; accession 0000950170-23-006456 (https://www.sec.gov/Archives/edgar/data/1676725/000095017023006456/idya-20221231.htm)
- [FY 2021 MD&A](/company/IDYA/mda/fy2021/): filed 2022-03-18; accession 0001564590-22-010922 (https://www.sec.gov/Archives/edgar/data/1676725/000156459022010922/idya-10k_20211231.htm)

Back to /company/IDYA/